FOOD AND DRUG ADMINISTRATION
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
MEETING ON PRESENTATION OF
LABORATORY OF RETROVIRUSES & LABORATORY OF IMMUNOREGULATION, DIVISION OF
VIRAL PRODUCTS; LABORATORY OF RESPIRATORY & SPECIAL PATHOGENS AND
LABORATORY OF METHODS DEVELOPMENT & QUALITY CONTROL, DIVISION OF BACTERIAL
PARASITIC & ALLERGENIC PRODUCTS
DRAFT AGENDA
September 22, 2005 1:30 PM EST
Food and Drug Administration, NIH campus
* FDA Building 29B, Conference Room C
8800 Rockville Pike, Bethesda, MD
1:30 p.m. Call to Order and Opening Remarks Dr. Gary Overturf, Chair
Christine Walsh, R.N., FDA
1:35 Conflict of Interest Statement Ethics and Integrity Staff
1:40 p.m. Open
Session
Overview of Laboratory Dr. Hana Golding, FDA
2:00 p.m. Laboratory
of Immunoregulation, Division of Viral Products
Overview of Laboratory Dr. Ira Berkower, FDA
2:20 p.m. Laboratory of Respiratory &
Special Pathogens, Division of Bacterial
Parasitic
& Allergenic Products
Overview of Laboratory Dr.
Drusilla L. Burns, FDA
2:40 p.m. Laboratory of Methods Development
& Quality Control, Division
of
Bacterial Parasitic & Allergenic Products
Overview of Laboratory Dr. Bruce D. Meade, FDA
3:00 p.m. Open Public Hearing (If
needed, otherwise will move directly to
closed session)
4:00 p.m. Closed Session
5:00 p.m. Adjournment
* The public may attend the meeting at the above location where equipment will be provided to allow public participation in the meeting.